Irina Petrache
Concepts (589)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 36 | 2026 | 277 | 9.560 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 25 | 2026 | 919 | 5.070 |
Why?
| | alpha 1-Antitrypsin | 16 | 2026 | 104 | 5.000 |
Why?
| | Ceramides | 24 | 2025 | 117 | 4.990 |
Why?
| | Lung Injury | 14 | 2026 | 241 | 4.750 |
Why?
| | Lung | 57 | 2026 | 4103 | 4.580 |
Why?
| | Apoptosis | 40 | 2026 | 2411 | 4.030 |
Why?
| | Smoking | 30 | 2020 | 1468 | 3.790 |
Why?
| | Endothelial Cells | 25 | 2025 | 866 | 3.770 |
Why?
| | Cigarette Smoking | 8 | 2022 | 101 | 3.200 |
Why?
| | Smoke | 12 | 2021 | 148 | 2.880 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 108 | 2.680 |
Why?
| | Vaping | 4 | 2026 | 69 | 2.360 |
Why?
| | Emphysema | 10 | 2023 | 100 | 2.320 |
Why?
| | alpha 1-Antitrypsin Deficiency | 9 | 2026 | 61 | 2.300 |
Why?
| | Sphingomyelin Phosphodiesterase | 7 | 2025 | 27 | 2.290 |
Why?
| | Sphingolipids | 8 | 2025 | 83 | 2.290 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 383 | 2.010 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 368 | 1.990 |
Why?
| | Acute Lung Injury | 4 | 2025 | 301 | 1.780 |
Why?
| | Hypertension, Pulmonary | 10 | 2026 | 1957 | 1.690 |
Why?
| | Animals | 91 | 2026 | 38141 | 1.380 |
Why?
| | Tobacco Products | 5 | 2021 | 84 | 1.310 |
Why?
| | Autophagy | 8 | 2026 | 288 | 1.310 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 951 | 1.300 |
Why?
| | Mice | 59 | 2026 | 18338 | 1.290 |
Why?
| | Oxidative Stress | 14 | 2026 | 1350 | 1.280 |
Why?
| | Signal Transduction | 20 | 2026 | 5202 | 1.240 |
Why?
| | Microvessels | 4 | 2021 | 98 | 1.230 |
Why?
| | Cells, Cultured | 23 | 2021 | 4127 | 1.130 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1212 | 1.100 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 120 | 1.050 |
Why?
| | Mice, Inbred C57BL | 28 | 2025 | 5989 | 1.050 |
Why?
| | MicroRNAs | 3 | 2026 | 689 | 1.020 |
Why?
| | Disease Models, Animal | 17 | 2026 | 4559 | 1.020 |
Why?
| | Pneumonia | 5 | 2021 | 632 | 0.950 |
Why?
| | Lipopolysaccharides | 5 | 2025 | 855 | 0.950 |
Why?
| | Caspase 3 | 7 | 2016 | 234 | 0.940 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 400 | 0.920 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1127 | 0.910 |
Why?
| | Membrane Proteins | 5 | 2022 | 1164 | 0.890 |
Why?
| | Inflammation | 9 | 2025 | 2883 | 0.870 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 227 | 0.860 |
Why?
| | Humans | 103 | 2026 | 145491 | 0.860 |
Why?
| | Adipose Tissue | 5 | 2017 | 644 | 0.850 |
Why?
| | Hypoxia | 6 | 2020 | 1199 | 0.850 |
Why?
| | Rats | 22 | 2017 | 5581 | 0.840 |
Why?
| | Up-Regulation | 10 | 2020 | 848 | 0.830 |
Why?
| | Endothelium | 4 | 2023 | 119 | 0.830 |
Why?
| | Neovascularization, Physiologic | 3 | 2020 | 191 | 0.830 |
Why?
| | Endocytosis | 3 | 2016 | 168 | 0.820 |
Why?
| | Epithelial Cells | 11 | 2026 | 1112 | 0.740 |
Why?
| | Vascular System Injuries | 1 | 2023 | 81 | 0.730 |
Why?
| | Mice, Knockout | 12 | 2025 | 3125 | 0.700 |
Why?
| | Phagocytosis | 3 | 2021 | 297 | 0.690 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.680 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.680 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.680 |
Why?
| | Rats, Sprague-Dawley | 14 | 2018 | 2526 | 0.650 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 17 | 0.620 |
Why?
| | Glucosylceramides | 1 | 2019 | 7 | 0.610 |
Why?
| | Translocation, Genetic | 1 | 2020 | 119 | 0.610 |
Why?
| | Immunoglobulins | 1 | 2020 | 162 | 0.610 |
Why?
| | Proteomics | 2 | 2026 | 1191 | 0.610 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 225 | 0.600 |
Why?
| | Estradiol | 3 | 2018 | 507 | 0.580 |
Why?
| | Glycoproteins | 1 | 2021 | 353 | 0.580 |
Why?
| | Bronchoalveolar Lavage Fluid | 8 | 2026 | 636 | 0.580 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 23 | 0.570 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 821 | 0.570 |
Why?
| | Macrophages | 4 | 2021 | 1509 | 0.570 |
Why?
| | Influenza, Human | 2 | 2022 | 623 | 0.560 |
Why?
| | Alpha-Globulins | 1 | 2018 | 19 | 0.550 |
Why?
| | Lysosomes | 2 | 2021 | 128 | 0.550 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 24 | 0.550 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 9 | 0.550 |
Why?
| | Sphingosine | 5 | 2015 | 45 | 0.540 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 441 | 0.540 |
Why?
| | Lung Diseases | 4 | 2025 | 783 | 0.540 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 342 | 0.540 |
Why?
| | Oncostatin M | 1 | 2017 | 6 | 0.530 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 6 | 0.530 |
Why?
| | Metformin | 1 | 2021 | 324 | 0.530 |
Why?
| | Male | 47 | 2026 | 72817 | 0.520 |
Why?
| | Thorax | 2 | 2022 | 51 | 0.510 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 461 | 0.510 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 172 | 0.490 |
Why?
| | Cell Death | 4 | 2019 | 383 | 0.490 |
Why?
| | Cell Movement | 4 | 2020 | 961 | 0.480 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 14 | 0.450 |
Why?
| | DNA Repair | 1 | 2018 | 256 | 0.450 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 72 | 0.450 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2355 | 0.450 |
Why?
| | Telemetry | 1 | 2015 | 40 | 0.440 |
Why?
| | Cytokines | 9 | 2019 | 2054 | 0.440 |
Why?
| | Cosmic Radiation | 1 | 2014 | 5 | 0.440 |
Why?
| | ADAM Proteins | 3 | 2022 | 64 | 0.440 |
Why?
| | DNA Damage | 1 | 2018 | 434 | 0.440 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 69 | 0.430 |
Why?
| | Mice, Transgenic | 8 | 2022 | 2189 | 0.430 |
Why?
| | Female | 36 | 2026 | 78763 | 0.430 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 268 | 0.420 |
Why?
| | Oxidoreductases | 4 | 2011 | 95 | 0.420 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.420 |
Why?
| | Palmitic Acids | 1 | 2014 | 10 | 0.420 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 13 | 0.410 |
Why?
| | Alginates | 1 | 2014 | 60 | 0.410 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 80 | 0.410 |
Why?
| | Enzyme Activation | 8 | 2015 | 762 | 0.410 |
Why?
| | Cell Proliferation | 9 | 2020 | 2499 | 0.400 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 81 | 0.400 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 138 | 0.400 |
Why?
| | Spinal Injuries | 1 | 2014 | 60 | 0.400 |
Why?
| | Influenza A virus | 2 | 2026 | 117 | 0.400 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 190 | 0.390 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 7 | 0.370 |
Why?
| | Tracheostomy | 1 | 2014 | 142 | 0.370 |
Why?
| | Lysophospholipids | 5 | 2015 | 78 | 0.370 |
Why?
| | Interleukin-6 | 1 | 2016 | 772 | 0.370 |
Why?
| | Nicotine | 1 | 2015 | 334 | 0.360 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 230 | 0.360 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 1173 | 0.350 |
Why?
| | Biomarkers | 9 | 2026 | 4283 | 0.340 |
Why?
| | Estrogens | 1 | 2014 | 364 | 0.340 |
Why?
| | Metabolomics | 5 | 2018 | 729 | 0.340 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 395 | 0.340 |
Why?
| | Photons | 1 | 2011 | 73 | 0.330 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 56 | 0.330 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 320 | 0.330 |
Why?
| | Stress, Physiological | 1 | 2014 | 452 | 0.320 |
Why?
| | Cell Differentiation | 2 | 2018 | 2045 | 0.320 |
Why?
| | Exercise Therapy | 1 | 2015 | 476 | 0.320 |
Why?
| | Virus Diseases | 2 | 2023 | 218 | 0.310 |
Why?
| | Adult Stem Cells | 1 | 2010 | 40 | 0.310 |
Why?
| | Hemodynamics | 1 | 2015 | 1116 | 0.310 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2030 | 0.310 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 53 | 0.310 |
Why?
| | Caspases | 3 | 2011 | 229 | 0.300 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 185 | 0.290 |
Why?
| | Phenotype | 7 | 2020 | 3157 | 0.290 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 303 | 0.280 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 39 | 0.280 |
Why?
| | Sphingomyelins | 3 | 2025 | 22 | 0.270 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 452 | 0.270 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 342 | 0.270 |
Why?
| | Vascular Remodeling | 4 | 2025 | 209 | 0.270 |
Why?
| | Cricetinae | 2 | 2026 | 299 | 0.260 |
Why?
| | Mass Spectrometry | 4 | 2018 | 744 | 0.260 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 563 | 0.260 |
Why?
| | Fibrinolysin | 1 | 2007 | 19 | 0.260 |
Why?
| | Heart | 1 | 2011 | 626 | 0.250 |
Why?
| | Predictive Value of Tests | 3 | 2026 | 2129 | 0.250 |
Why?
| | Transcription Factors | 2 | 2012 | 1733 | 0.250 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1487 | 0.250 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2016 | 149 | 0.250 |
Why?
| | Mesocricetus | 1 | 2026 | 49 | 0.250 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 632 | 0.240 |
Why?
| | Electric Impedance | 3 | 2015 | 110 | 0.240 |
Why?
| | Thrombin | 1 | 2007 | 167 | 0.240 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 108 | 0.230 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2594 | 0.230 |
Why?
| | ADAM17 Protein | 2 | 2017 | 42 | 0.230 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 187 | 0.230 |
Why?
| | Middle Aged | 12 | 2026 | 36176 | 0.220 |
Why?
| | Leukocytes | 3 | 2022 | 295 | 0.220 |
Why?
| | Cell Adhesion | 2 | 2020 | 452 | 0.220 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 371 | 0.220 |
Why?
| | Forced Expiratory Volume | 1 | 2026 | 450 | 0.210 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 127 | 0.210 |
Why?
| | Caspase 6 | 2 | 2016 | 3 | 0.210 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.210 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 667 | 0.210 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 25 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2772 | 0.200 |
Why?
| | Capillary Permeability | 2 | 2015 | 132 | 0.200 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 17 | 0.190 |
Why?
| | Homeostasis | 3 | 2018 | 639 | 0.190 |
Why?
| | Monocytes | 4 | 2023 | 536 | 0.190 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 19 | 0.190 |
Why?
| | Biomedical Technology | 1 | 2024 | 49 | 0.190 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 78 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 373 | 0.190 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 56 | 0.190 |
Why?
| | Cell Line | 4 | 2017 | 2823 | 0.190 |
Why?
| | Respiratory System | 1 | 2024 | 151 | 0.190 |
Why?
| | Oxygen Consumption | 2 | 2022 | 718 | 0.180 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 181 | 0.180 |
Why?
| | Primary Cell Culture | 2 | 2013 | 172 | 0.180 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 108 | 0.180 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1261 | 0.170 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 262 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2023 | 223 | 0.170 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 9 | 0.170 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.170 |
Why?
| | Flow Cytometry | 4 | 2015 | 1156 | 0.170 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.170 |
Why?
| | CD11 Antigens | 1 | 2021 | 29 | 0.170 |
Why?
| | CD11b Antigen | 1 | 2021 | 60 | 0.170 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 41 | 0.170 |
Why?
| | Lectins | 1 | 2021 | 45 | 0.170 |
Why?
| | Cell Size | 1 | 2021 | 92 | 0.170 |
Why?
| | Kinetics | 3 | 2015 | 1605 | 0.170 |
Why?
| | Cytoskeleton | 3 | 2011 | 198 | 0.170 |
Why?
| | Societies, Medical | 2 | 2023 | 898 | 0.160 |
Why?
| | Blotting, Western | 4 | 2011 | 1162 | 0.160 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.160 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.160 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 25 | 0.160 |
Why?
| | Inhalation Exposure | 1 | 2021 | 103 | 0.160 |
Why?
| | Microtubules | 1 | 2003 | 287 | 0.160 |
Why?
| | Integrin beta1 | 1 | 2020 | 33 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 294 | 0.160 |
Why?
| | Risk Factors | 5 | 2024 | 10874 | 0.160 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 91 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2020 | 57 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 80 | 0.160 |
Why?
| | Lactic Acid | 1 | 2022 | 306 | 0.160 |
Why?
| | Tobacco Smoking | 1 | 2020 | 26 | 0.160 |
Why?
| | Sirolimus | 1 | 2021 | 280 | 0.150 |
Why?
| | Dronabinol | 1 | 2023 | 249 | 0.150 |
Why?
| | Oxidants | 2 | 2011 | 103 | 0.150 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 79 | 0.150 |
Why?
| | Stromal Cells | 2 | 2017 | 120 | 0.150 |
Why?
| | Ischemia | 2 | 2018 | 430 | 0.150 |
Why?
| | Cell Membrane | 3 | 2013 | 707 | 0.150 |
Why?
| | Biological Assay | 2 | 2021 | 129 | 0.150 |
Why?
| | Collagen Type V | 2 | 2009 | 4 | 0.150 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 17 | 0.140 |
Why?
| | Exercise Test | 1 | 2022 | 628 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2017 | 3619 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 376 | 0.140 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 8 | 0.140 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 191 | 0.140 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 177 | 0.140 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 161 | 0.140 |
Why?
| | Cell Survival | 3 | 2018 | 1094 | 0.140 |
Why?
| | Eosinophils | 1 | 2021 | 316 | 0.140 |
Why?
| | Paclitaxel | 2 | 2014 | 256 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 210 | 0.140 |
Why?
| | Fatty Acids | 1 | 2022 | 459 | 0.140 |
Why?
| | Benzylamines | 1 | 2018 | 44 | 0.140 |
Why?
| | beta Catenin | 1 | 2020 | 253 | 0.140 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.140 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 4 | 0.140 |
Why?
| | Imipramine | 1 | 2018 | 11 | 0.140 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 40 | 0.140 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 43 | 0.140 |
Why?
| | Hot Temperature | 1 | 2021 | 411 | 0.140 |
Why?
| | Gene Expression | 2 | 2021 | 1478 | 0.130 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 86 | 0.130 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 138 | 0.130 |
Why?
| | Oxygen | 2 | 2014 | 986 | 0.130 |
Why?
| | Morphine | 2 | 2009 | 170 | 0.130 |
Why?
| | Cell Hypoxia | 4 | 2020 | 248 | 0.130 |
Why?
| | Aged | 6 | 2026 | 26125 | 0.130 |
Why?
| | Carbon Monoxide | 1 | 2018 | 82 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 482 | 0.130 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 284 | 0.130 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 74 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 551 | 0.130 |
Why?
| | Disease Outbreaks | 1 | 2020 | 426 | 0.130 |
Why?
| | Adult | 10 | 2022 | 40707 | 0.120 |
Why?
| | THP-1 Cells | 1 | 2016 | 20 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 287 | 0.120 |
Why?
| | Bone Marrow | 1 | 2018 | 307 | 0.120 |
Why?
| | Transcriptome | 3 | 2018 | 1038 | 0.120 |
Why?
| | Adipocytes | 1 | 2018 | 223 | 0.120 |
Why?
| | Spinal Cord | 2 | 2009 | 384 | 0.120 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 45 | 0.120 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 98 | 0.120 |
Why?
| | Time Factors | 3 | 2018 | 7171 | 0.120 |
Why?
| | Protein Kinases | 1 | 2018 | 314 | 0.120 |
Why?
| | Protein Binding | 3 | 2018 | 2250 | 0.120 |
Why?
| | Bronchi | 1 | 2017 | 263 | 0.120 |
Why?
| | Monocrotaline | 1 | 2015 | 31 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1706 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 225 | 0.110 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 74 | 0.110 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 84 | 0.110 |
Why?
| | Lung Transplantation | 2 | 2009 | 330 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2022 | 948 | 0.110 |
Why?
| | Asthma | 2 | 2020 | 1795 | 0.110 |
Why?
| | Actins | 3 | 2018 | 421 | 0.110 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 392 | 0.110 |
Why?
| | Ventricular Pressure | 1 | 2015 | 52 | 0.110 |
Why?
| | Neutrophils | 1 | 2021 | 1124 | 0.110 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 57 | 0.110 |
Why?
| | Binding, Competitive | 1 | 2015 | 182 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Myelopoiesis | 1 | 2015 | 10 | 0.110 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.110 |
Why?
| | Aging | 2 | 2021 | 1940 | 0.110 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 141 | 0.110 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 87 | 0.110 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 112 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 419 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 294 | 0.110 |
Why?
| | Collagen Type VI | 1 | 2014 | 5 | 0.110 |
Why?
| | Hexuronic Acids | 1 | 2014 | 29 | 0.110 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 11 | 0.110 |
Why?
| | Glucuronic Acid | 1 | 2014 | 30 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 254 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 203 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2945 | 0.100 |
Why?
| | Arterial Pressure | 1 | 2015 | 134 | 0.100 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 40 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 456 | 0.100 |
Why?
| | Propylene Glycols | 2 | 2014 | 28 | 0.100 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 49 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 74 | 0.100 |
Why?
| | Hyperoxia | 1 | 2015 | 96 | 0.100 |
Why?
| | HMGB1 Protein | 1 | 2014 | 51 | 0.100 |
Why?
| | Ligands | 3 | 2023 | 667 | 0.100 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 55 | 0.100 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 248 | 0.100 |
Why?
| | Paracrine Communication | 1 | 2014 | 67 | 0.100 |
Why?
| | Metabolome | 1 | 2017 | 387 | 0.100 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 49 | 0.100 |
Why?
| | Oligopeptides | 2 | 2014 | 266 | 0.100 |
Why?
| | Ventricular Remodeling | 2 | 2015 | 277 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 196 | 0.100 |
Why?
| | Virulence | 1 | 2014 | 282 | 0.100 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 5 | 0.100 |
Why?
| | Calpain | 1 | 2013 | 61 | 0.100 |
Why?
| | Glycolysis | 1 | 2015 | 342 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 437 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 550 | 0.100 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 16 | 0.100 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 31 | 0.100 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 18 | 0.100 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 45 | 0.100 |
Why?
| | Cattle | 3 | 2008 | 977 | 0.090 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 306 | 0.090 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 45 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2146 | 0.090 |
Why?
| | Lung Compliance | 1 | 2012 | 42 | 0.090 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 296 | 0.090 |
Why?
| | United States | 4 | 2024 | 16115 | 0.090 |
Why?
| | HIV Infections | 3 | 2017 | 3189 | 0.090 |
Why?
| | Proteolysis | 1 | 2013 | 170 | 0.090 |
Why?
| | Neuralgia | 1 | 2014 | 148 | 0.090 |
Why?
| | Drug Tolerance | 2 | 2009 | 99 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 37 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 64 | 0.090 |
Why?
| | Liposomes | 1 | 2014 | 259 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 436 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 63 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5891 | 0.090 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 7 | 0.090 |
Why?
| | Cardiac Output | 1 | 2012 | 179 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1304 | 0.090 |
Why?
| | Catalase | 1 | 2011 | 133 | 0.080 |
Why?
| | Goblet Cells | 1 | 2011 | 22 | 0.080 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 150 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 1049 | 0.080 |
Why?
| | Bronchioles | 1 | 2011 | 29 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2013 | 390 | 0.080 |
Why?
| | Immunization, Passive | 1 | 2011 | 90 | 0.080 |
Why?
| | Permeability | 1 | 2011 | 169 | 0.080 |
Why?
| | Ceramidases | 1 | 2010 | 4 | 0.080 |
Why?
| | Microcirculation | 1 | 2011 | 142 | 0.080 |
Why?
| | Inflammasomes | 1 | 2012 | 145 | 0.080 |
Why?
| | Phosphorylation | 1 | 2015 | 1707 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 231 | 0.080 |
Why?
| | Acetylcysteine | 1 | 2011 | 137 | 0.080 |
Why?
| | Plant Extracts | 1 | 2012 | 188 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2010 | 115 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 396 | 0.080 |
Why?
| | Carcinogens | 1 | 2011 | 123 | 0.080 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 56 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 626 | 0.080 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 1150 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 413 | 0.080 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 169 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 932 | 0.080 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 49 | 0.080 |
Why?
| | Perfusion | 1 | 2011 | 249 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 570 | 0.080 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 10 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 140 | 0.080 |
Why?
| | Exercise | 1 | 2022 | 2192 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1710 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 426 | 0.070 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 430 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2013 | 693 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 88 | 0.070 |
Why?
| | Clathrin | 1 | 2009 | 26 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2017 | 2820 | 0.070 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 1080 | 0.070 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 40 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2014 | 754 | 0.070 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 420 | 0.070 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 11 | 0.070 |
Why?
| | Mutation | 1 | 2020 | 4093 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 102 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 842 | 0.070 |
Why?
| | Protein Precursors | 1 | 2009 | 136 | 0.070 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 100 | 0.070 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1468 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 3537 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 213 | 0.070 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 10 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 266 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 846 | 0.070 |
Why?
| | Cyclosporine | 1 | 2009 | 256 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 265 | 0.070 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 52 | 0.070 |
Why?
| | Software | 1 | 2013 | 698 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 2110 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 289 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 39 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 254 | 0.070 |
Why?
| | Transglutaminases | 1 | 2008 | 159 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 365 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 51 | 0.070 |
Why?
| | Superoxides | 1 | 2008 | 199 | 0.060 |
Why?
| | Obesity | 2 | 2020 | 3076 | 0.060 |
Why?
| | Antibody Formation | 1 | 2008 | 291 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 338 | 0.060 |
Why?
| | Organ Size | 1 | 2008 | 461 | 0.060 |
Why?
| | Cell-Free System | 1 | 2006 | 53 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2023 | 772 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2582 | 0.060 |
Why?
| | Cisplatin | 1 | 2008 | 345 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 519 | 0.060 |
Why?
| | Indoles | 1 | 2009 | 508 | 0.060 |
Why?
| | Capillaries | 1 | 2006 | 120 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1188 | 0.060 |
Why?
| | Hepatocytes | 1 | 2026 | 224 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 199 | 0.060 |
Why?
| | Antigens, CD | 2 | 2011 | 557 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 55 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1782 | 0.050 |
Why?
| | Acyltransferases | 1 | 2005 | 78 | 0.050 |
Why?
| | Deoxyguanosine | 1 | 2004 | 25 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1794 | 0.050 |
Why?
| | Regeneration | 1 | 2006 | 198 | 0.050 |
Why?
| | Weight Loss | 1 | 2010 | 839 | 0.050 |
Why?
| | Disease Progression | 1 | 2012 | 2862 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2008 | 890 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 20 | 0.050 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 12 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 18 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 24 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 80 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 47 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 133 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 82 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 397 | 0.040 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 595 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1511 | 0.040 |
Why?
| | Imidazoles | 1 | 2003 | 246 | 0.040 |
Why?
| | Cell Communication | 1 | 2023 | 326 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 359 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 310 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 372 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2664 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1512 | 0.040 |
Why?
| | Fever | 1 | 2022 | 317 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2207 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 7 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 85 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 117 | 0.040 |
Why?
| | Neurons | 1 | 2008 | 1647 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 751 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 35 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 571 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 733 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 118 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 360 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 607 | 0.040 |
Why?
| | Swine | 1 | 2021 | 833 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 377 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 376 | 0.030 |
Why?
| | Cohort Studies | 2 | 2020 | 5992 | 0.030 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 21 | 0.030 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 27 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2020 | 264 | 0.030 |
Why?
| | Propionates | 1 | 2018 | 38 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2022 | 529 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1082 | 0.030 |
Why?
| | Vital Capacity | 1 | 2018 | 292 | 0.030 |
Why?
| | Protein Stability | 1 | 2018 | 178 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 122 | 0.030 |
Why?
| | Nitriles | 1 | 2018 | 205 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1378 | 0.030 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 151 | 0.030 |
Why?
| | RNA | 1 | 2023 | 929 | 0.030 |
Why?
| | HIV | 1 | 2017 | 252 | 0.030 |
Why?
| | Weight Gain | 1 | 2020 | 557 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 116 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 862 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 549 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1816 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 660 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2130 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 389 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 78 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 383 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 276 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 171 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 61 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 6 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 130 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 104 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1039 | 0.030 |
Why?
| | Indans | 1 | 2014 | 13 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 37 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 143 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 242 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 316 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 14192 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 543 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 566 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 369 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 84 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 61 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 97 | 0.030 |
Why?
| | Cricetulus | 1 | 2013 | 115 | 0.020 |
Why?
| | Thiazoles | 1 | 2014 | 139 | 0.020 |
Why?
| | Thiophenes | 1 | 2014 | 121 | 0.020 |
Why?
| | CHO Cells | 1 | 2013 | 166 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2020 | 846 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 17269 | 0.020 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 4 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 130 | 0.020 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 24 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 613 | 0.020 |
Why?
| | Lipid Bilayers | 1 | 2014 | 101 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1896 | 0.020 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 42 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 133 | 0.020 |
Why?
| | Hydrolases | 1 | 2013 | 55 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 163 | 0.020 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 39 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 890 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 166 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 573 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 505 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 335 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 207 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 219 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1244 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1026 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 57 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 75 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 175 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 562 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 2002 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 407 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 2330 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 104 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 55 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 76 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 123 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2506 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 511 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 9 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 246 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 55 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 125 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 153 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1500 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 863 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1046 | 0.010 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 929 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8326 | 0.010 |
Why?
| | Pleura | 1 | 2005 | 28 | 0.010 |
Why?
| | Ligation | 1 | 2005 | 91 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1855 | 0.010 |
Why?
| | Postural Balance | 1 | 2008 | 246 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 120 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 113 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 407 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 79 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 878 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 249 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1996 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 993 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11831 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1815 | 0.010 |
Why?
| | Child | 1 | 2017 | 22680 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|